Literature DB >> 11714050

Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit.

A Lang1, G De Fina, R Meyer, R Aschbacher, F Rizza, O Mayr, M Casini.   

Abstract

The objective of the study presented here was to compare antimicrobial use and resistance of bacterial isolates in the haematology ward and the intensive care unit of Bolzano General Hospital. The bacterial organisms isolated most frequently from patients in the two wards (coagulase-negative staphylococci, Enterococcus spp., and Pseudomonas aeruginosa) were investigated for antimicrobial resistance. Isolates obtained from patients in the haematology ward were more often resistant to antimicrobial agents than isolates obtained from patients in the intensive care unit, and the agents against which the highest rates of resistance were found were third- and fourth-generation cephalosporins, carbapenems and monobactams, quinolones, aminoglycosides, and trimethoprim-sulfamethoxazole. These classes of antimicrobial agents were also used more frequently in the haematology ward than in the intensive care unit. Conversely, penicillinic beta-lactam antibiotics, rifamycins, macrolides and lincosamides were used less frequently in the haematology ward than in the intensive care unit, and the rates of resistance against these classes of antimicrobial agents were significantly lower in the haematology ward than in the intensive care unit. The results support the hypothesis that a causal relationship exists between antimicrobial use and the development of resistance and indicate that careful monitoring of antimicrobial use in hospitals is required to identify situations in which prescription patterns are contributing to the development of resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714050     DOI: 10.1007/s100960100582

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Authors:  W V Kern; K Klose; A S Jellen-Ritter; M Oethinger; J Bohnert; P Kern; S Reuter; H von Baum; R Marre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Prior antimicrobial therapy in the hospital and other predisposing factors influencing the usage of antibiotics in a pediatric critical care unit.

Authors:  George Briassoulis; Labrini Natsi; Athina Tsorva; Tassos Hatzis
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-04-17       Impact factor: 3.944

3.  Prevalence of infectious multi-drug resistant bacteria isolated from immunocompromised patients in Tunisia.

Authors:  Arij Mechergui; Wafa Achour; Sondos Mathlouthi; Assia Ben Hassen
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

4.  Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study.

Authors:  Wataru Mimura; Haruhisa Fukuda; Manabu Akazawa
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-02-17       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.